VirtualBackroom.ai

AI-Powered Regulatory Compliance Platform for Medical Device Companies

Pre-Release Prototype - For training and advisory purposes only
Knowledge cut-off: June 04, 2026

Platform Overview

VirtualBackroom.ai is a comprehensive AI-powered regulatory compliance platform designed specifically for medical device companies navigating complex healthcare regulations.

Mission

To simplify regulatory compliance workflows by providing intelligent audit simulations, real-time guidance, and multi-modal AI assistance that helps quality and regulatory professionals work more efficiently.

Technology

Built with multi-provider AI integration (Gemini, OpenAI, Anthropic, Perplexity) featuring intelligent fallback mechanisms to ensure reliable responses for your regulatory questions.

Key Value Proposition

VirtualBackroom.ai acts as your virtual regulatory affairs consultant, available 24/7 to answer questions, validate citations, simulate audits, and guide you through complex compliance requirements.

QMSR Transition Support

FDA Quality Management System Regulation (QMSR)

The FDA Quality Management System Regulation (QMSR) replaced 21 CFR Part 820 Quality System Regulation (QSR) by incorporating ISO 13485:2016 by reference. The rule has been in effect since February 2, 2026; FDA inspections are now conducted under the QMSR-aligned approach in place of the legacy QSIT technique.

In Effect Since

February 02, 2026

122 days in effect

What Changes with QMSR?
Incorporated by Reference

ISO 13485:2016 becomes the foundation, replacing most QSR subparts with "[Reserved]" designations.

New FDA-Specific Sections

Two new sections require special attention: §820.35 (Control of Records) and §820.45 (Device Labeling and Packaging Controls).

QMSR Tools Available
  • QMSR Readiness Snapshot - Self-assessment questionnaire aligned to ISO 13485:2016 subclauses
  • QMSR Audit Coach - Interactive audit simulations with AI-powered feedback
  • QSR-QMSR Structure Comparison - Side-by-side mapping of old vs. new regulatory structure
  • Definition Hierarchy - 13 comprehensive FDA-specific terms with categorization
  • Citation Validation - Validates QMSR sections, ISO 13485 clauses, legacy QSR, MDR, and UDI citations

Intended Use

VirtualBackroom.ai is a regulatory compliance coaching and readiness assessment tool for medical device quality professionals.

It is classified as an advisory and educational tool. It is not a Quality Management System (QMS), document management system, eQMS, or regulatory submission tool. AI on this platform cannot make compliance decisions, close CAPAs, approve deviations, author documents for regulatory submission, or replace qualified human review.

For a complete description of AI capabilities and limitations, see our AI Boundaries & Intended Use page, including reviewer guidance for evaluating AI outputs aligned with FDA GMLP Principle #7.

AI Governance & Compliance

VirtualBackroom.ai implements a Validated AI Operating Model aligned with 21 CFR Part 11 and EU Annex 11 requirements for AI systems in regulated environments.

AI Audit Trail

Complete logging of all AI interactions with:

  • User attribution (who made the request)
  • Timestamps (when it occurred)
  • Model information (which AI was used)
  • SHA-256 hashing for data integrity
  • Chain integrity verification
View Audit Trail
21 CFR Part 11 / Annex 11

Comprehensive knowledge base covering:

  • Electronic records requirements
  • Electronic signatures validation
  • ALCOA+ data integrity principles
  • GAMP 5 software validation categories
  • AI/ML validation considerations
View Knowledge Base
AI Validation Service

Quality assurance for AI-generated content:

  • Hallucination detection (pattern recognition)
  • Citation verification against regulatory standards
  • Confidence scoring for responses
  • Council Mode consensus analysis
Record Immutability

Tamper-evident audit records:

  • Append-only audit log architecture
  • Record locking after creation
  • Chain integrity linking records
  • Database-level hash verification
ALCOA+ Compliance

All AI audit records follow ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available.

Global Regulatory Milestones

Key compliance milestones for medical device manufacturers across global markets — including upcoming deadlines and frameworks already in effect. Plan ahead and verify status against official sources.

EU AI Act - High-Risk AI Systems
EU

Obligations for high-risk AI systems under Regulation (EU) 2024/1689 begin to apply, including risk management, data governance, human oversight, and post-market monitoring duties relevant to AI/ML medical device software.

August 02, 2026 59 days!
EU IVDR - Class B / Class A Sterile (Application)
EU

Application milestone under Regulation (EU) 2024/1860: Class B and Class A sterile legacy IVDs must lodge a Notified Body application by this date to retain transitional benefits.

May 26, 2027 356 days
EU MDR - Class III & Class IIb Implantable
EU

Extended transition deadline under Regulation (EU) 2023/607 for Class III and Class IIb implantable legacy devices under MDR 2017/745.

December 31, 2027 575 days
UKCA Marking - General Medical Devices
UK

MHRA acceptance of EU CE-marked general medical devices in Great Britain ends on the earlier of certificate expiry or this date; UKCA or new UK framework conformity required thereafter.

June 30, 2028 757 days
EU MDR - Class IIb Non-Implantable, IIa, Is/Im
EU

Extended transition deadline under Regulation (EU) 2023/607 for Class IIb non-implantable, Class IIa, and Class I sterile/measuring/reusable surgical legacy devices.

December 31, 2028 941 days
UKCA Marking - IVDs
UK

MHRA acceptance of EU CE-marked in vitro diagnostic devices in Great Britain ends on the earlier of certificate expiry or this date.

June 30, 2030 1487 days
EU IVDR - Class C (Notified Body Application)
EU

Final milestone under Regulation (EU) 2024/1860: manufacturers of Class C legacy IVDs must lodge a formal certification application with a Notified Body by this date or lose extended-transition coverage.

May 26, 2026 Past
FDA QMSR
US

Quality Management System Regulation (21 CFR Part 820, incorporating ISO 13485:2016) is now in effect. FDA inspections use the new QMSR-aligned approach in place of the legacy QSIT.

February 02, 2026 In effect · 122d
FDA UDI - Class I
US

UDI labeling and GUDID submission requirements for Class I and unclassified devices are now fully enforced.

September 24, 2025 In effect · 253d
Health Canada MDSAP
Canada

A valid MDSAP certificate (with Canada in scope) is mandatory for Class II, III, and IV Medical Device Licences. Mandatory since January 1, 2019; no alternative ISO 13485 routes accepted.

January 01, 2019 In effect · 2711d
Regional Legend

US United States (FDA) EU European Union (MDR/IVDR) UK United Kingdom (MHRA) Canada Health Canada

Verify dates with official sources

Core Features

QMSR Audit Coach

Interactive audit simulations that test your knowledge of regulatory requirements. Get AI-powered feedback on your responses and track your progress over time.

  • Scenario-based audit questions
  • Real-time AI feedback
  • Performance tracking and history
QMSR Readiness Snapshot

Comprehensive self-assessment questionnaire with 50 questions aligned to ISO 13485:2016 subclauses covering all major QMS areas.

  • Clause 4-8 coverage
  • Gap identification
  • Prioritized action items
Citation Validation

Intelligent citation validation supporting multiple regulatory formats with cross-reference mapping.

  • QMSR sections (§820.x)
  • ISO 13485 clauses
  • MDR (21 CFR 803) and UDI (21 CFR 830)
Regulatory Browser

Access and explore 16+ regulatory standards including ISO, FDA, and EU MDR with cross-references between equivalent sections.

  • Full-text search
  • Cross-standard mapping
  • Citation linking
Regulatory Assistant

AI-powered conversational assistant for regulatory compliance questions with citation suggestions for your documentation.

  • Natural language queries
  • Context-aware responses
  • Citation recommendations
Global Regulatory Monitor

Real-time monitoring of regulatory news and updates from 36 regulatory bodies across 6 major regions worldwide.

  • Live news aggregation
  • Trending topics extraction
  • Alert notifications

Getting Started

1
Create Account

Register for a free account to access all platform features and save your progress.

2
Take Assessment

Complete the QMSR Readiness Snapshot to identify gaps in your current QMS compliance.

3
Practice & Learn

Use the Audit Coach simulations and Regulatory Browser to build compliance expertise.

Pro Tip

Toggle between Simple Mode (3 core features) and Pro Mode (all advanced tools) using the button in the navigation bar to customize your experience.

Regulatory Knowledge Framework

VirtualBackroom.ai incorporates a comprehensive reference map of global medical device regulations:

Core Regulatory Authorities
FDA (US)21 CFR Part 820 (QMSR), 21 CFR Part 803 (MDR)
EUMDR (2017/745), IVDR (2017/746)
CanadaHealth Canada CMDCAS
AustraliaTGA
JapanPMDA
ChinaNMPA
BrazilANVISA
KoreaMFDS
Global Standards
ISO 13485Quality Management Systems
ISO 14971Risk Management
IEC 62304Software Lifecycle
IEC 60601-1Electrical Safety
ISO 10993Biocompatibility
ISO 11135Sterilization

Latest Updates

Recent platform releases, in reverse chronological order. Most recent at the top.

  • v3.1 Knowledge Refresh & Post-QMSR Compliance Update
    2026-05-03
    Compliance
    • Knowledge cut-off advanced to May 3, 2026 across the platform.
    • FDA QMSR reframed as 'In effect since Feb 2, 2026' with days-in-effect counter.
    • Regulatory milestones rebuilt against Reg. (EU) 2023/607 (MDR) and Reg. (EU) 2024/1860 (IVDR application milestones).
    • Added EU AI Act (Reg. 2024/1689) high-risk obligations milestone (Aug 2, 2026).
    • UKCA / GB CE-acceptance dates separated for general devices (Jun 30, 2028) vs IVDs (Jun 30, 2030).
    • MDSAP entry updated: presented as mandatory in Canada since Jan 1, 2019.
    • AI Boundaries and Security & Privacy pages: review stamp refreshed to May 2026.
  • v3.0 Post-QMSR: Validated AI Operating Model
    2026-02-05
    Compliance
    • AI Audit Trail with SHA-256 hashing and chain integrity (21 CFR Part 11).
    • 21 CFR Part 11 / EU Annex 11 knowledge base at /qmsr/electronic-records-guide.
    • FDA Inspection Guide knowledge base (CPM 7382.850).
    • Audit workflow rewritten on JSON blob persistence with auto-save.
    • FAQ page launched with 12 regulatory compliance questions.
  • v2.5 QMSR Launch Readiness
    2026-01-25
    Feature
    • Council Mode expanded to 8 expert AI models.
    • AI-powered Mind Map generator with Mermaid.js rendering.
    • Document-based Gap Analysis with PDF/DOCX/TXT upload and PDF export.
    • Partner demo and 8-slide presentation pages.
    • Stripe subscription tiers (Free / Pro $49/mo) with feature gating.
  • v2.0 Security Hardening
    2025-12-30
    Security
    • Firebase config moved server-side; CSRF protection enabled globally.
    • Redis-backed rate limiting on auth and API endpoints.
    • Comprehensive input validation layer across auth, API, and AI inputs.
    • Invite-only access with @login_required on all protected routes.
  • v1.0 Initial Platform Release
    2025-11-01
    Feature
    • Flask blueprint architecture with PostgreSQL backend.
    • Multi-provider AI router (Gemini, OpenAI, Anthropic, Perplexity).
    • Audit simulations, citation suggestions, and regulatory browser.
    • Chrome extension with QMSR self-assessment and audit simulations.

Important Disclaimers

Pre-Release Status

This is a pre-release prototype for regulatory compliance coaching and training purposes only. Do not rely on AI outputs for official compliance decisions without independent qualified human review.

No Regulatory or Legal Advice

VirtualBackroom.ai does not provide regulatory advice, legal advice, or legal opinions. All content is advisory and educational. Organizations must consult qualified regulatory affairs professionals and legal counsel for official compliance decisions. The authoritative sources for all regulatory requirements are the official publications from FDA, EU Commission, ISO, and applicable national regulatory authorities.

Data Privacy

DO NOT upload or paste patient data, protected health information (PHI), personally identifiable information (PII), or confidential trade secrets. Automated PII/PHI sanitization is applied but is not guaranteed to catch all sensitive data patterns.

Assessments Are Self-Reported

QMSR Readiness Snapshots and gap analyses are self-reported assessments and are not a substitute for formal internal audits or notified body reviews. AI-generated findings require verification by qualified personnel before use in quality system decisions.